Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis As Assessed By Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data

被引：0

作者：

Maksymowych, Walter P. ^{[1
]}

Strand, Vibeke ^{[2
]}

Nash, Peter ^{[3
]}

Thom, Howard ^{[4
]}

Karabis, Andreas ^{[5
]}

Gandhi, Kunal ^{[6
]}

Porter, Brian ^{[6
]}

Jugl, Steffen ^{[7
]}

机构：

[1] Univ Alberta, Edmonton, AB, Canada

[2] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA

[3] Univ Queensland, Dept Med, Brisbane, Qld, Australia

[4] Univ Bristol, Bristol, Avon, England

[5] MAPI Grp, Houten, Netherlands

[6] Novartis Pharmaceut, E Hanover, NJ USA

[7] Novartis Pharma AG, Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1739

引用

页数：3